We are live on ! Find out more
Klingenstein Fields & Co

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B Turnover 11.39%
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+19.63%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.86B
AUM Growth
+$322M
Cap. Flow
-$15.2M
Cap. Flow %
-0.53%
Top 10 Hldgs %
39.67%
Holding
202
New
16
Increased
51
Reduced
70
Closed
7
Avg Time Held
7 years
Top 10 Avg Time Held
4.1 years
Top 20 Avg Time Held
5.4 years

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$18.3M
2
ZS icon
Zscaler
ZS
+$12.3M
3
LLY icon
Eli Lilly
LLY
+$11.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$10.1M
5
SYK icon
Stryker
SYK
+$9.31M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Communication Services 14.16%
3 Miscellaneous 13.05%
4 Financials 11.41%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BIIB icon
126
Biogen
BIIB
$34.5B
$590K 0.02%
2,731
– –
2022 Q3
15 quarters
TSLA icon
127
Tesla
TSLA
$1.45T
$557K 0.02%
1,324
+137
+12% +$54.5K
2023 Q1
13 quarters
FDX icon
128
FedEx
FDX
$69.5B
$555K 0.02%
1,773
+8
+0.5% +$2.91K
2013 Q2
52 quarters
IJH icon
129
iShares Core S&P Mid-Cap ETF
IJH
$121B
$530K 0.02%
6,868
– –
2025 Q4
2 quarters
GLW icon
130
Corning
GLW
$114B
$526K 0.02%
2,060
– –
2026 Q1
1 quarter
IWO icon
131
iShares Russell 2000 Growth ETF
IWO
$13.4B
$524K 0.02%
1,331
– –
2017 Q2
36 quarters
VRTX icon
132
Vertex Pharmaceuticals
VRTX
$127B
$514K 0.02%
1,035
+30
+3% +$13.3K
2024 Q1
9 quarters
VWO icon
133
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$514K 0.02%
8,603
– –
2017 Q2
36 quarters
CWI icon
134
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.84B
$512K 0.02%
12,596
– –
2013 Q2
52 quarters
BNY icon
135
Bank of New York Mellon
BNY
$96.6B
$506K 0.02%
3,501
-18
-0.5% -$2.46K
2013 Q2
52 quarters
IWM icon
136
iShares Russell 2000 ETF
IWM
$77.8B
$503K 0.02%
1,673
– –
2025 Q3
3 quarters
NVS icon
137
Novartis
NVS
$285B
$478K 0.02%
3,047
– –
2013 Q2
52 quarters
AMD icon
138
Advanced Micro Devices
AMD
$878B
$466K 0.02%
+802
New +$329K
2026 Q2
0 quarters
REGN icon
139
Regeneron Pharmaceuticals
REGN
$80.5B
$466K 0.02%
747
-14,819
-95% -$10.1M
2020 Q4
22 quarters
NVO icon
140
Novo Nordisk
NVO
$170B
$450K 0.02%
9,380
-440
-4% -$18.9K
2013 Q2
52 quarters
CFG icon
141
Citizens Financial Group
CFG
$26.4B
$449K 0.02%
6,402
– –
2023 Q2
12 quarters
ITOT icon
142
iShares Core S&P Total US Stock Market ETF
ITOT
$96.3B
$448K 0.02%
2,727
-1,020
-27% -$162K
2020 Q3
23 quarters
CSCO icon
143
Cisco
CSCO
$420B
$446K 0.02%
3,798
+106
+3% +$11.1K
2013 Q2
52 quarters
LIN icon
144
Linde
LIN
$232B
$439K 0.02%
846
-30
-3% -$15.2K
2021 Q3
19 quarters
IP icon
145
International Paper
IP
$17.9B
$433K 0.02%
11,365
– –
2013 Q2
52 quarters
AMGN icon
146
Amgen
AMGN
$230B
$414K 0.01%
1,142
– –
2020 Q2
24 quarters
QCOM icon
147
Qualcomm
QCOM
$185B
$413K 0.01%
2,237
– –
2013 Q2
52 quarters
WFC icon
148
Wells Fargo
WFC
$246B
$405K 0.01%
4,901
-10
-0.2% -$804
2023 Q2
12 quarters
EXEL icon
149
Exelixis
EXEL
$15.5B
$391K 0.01%
7,178
+178
+3% +$8.67K
2024 Q4
6 quarters
USRT icon
150
iShares Core US REIT ETF
USRT
$4.17B
$390K 0.01%
5,867
– –
2023 Q2
12 quarters

Similar funds

Klingenstein Fields & Co's Q2 2026 Portfolio in Review

As of Q2 2026, Klingenstein Fields & Co held 202 positions worth $2.86B, up 13% from $2.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Klingenstein Fields & Co's Q2 2026 filing shows 16 new, 51 increased, 70 reduced and 7 closed positions. Its largest new stake was Honeywell Aerospace: 81,559 shares worth $18M. The largest sale was Honeywell, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Communication Services and Miscellaneous.

  • Klingenstein Fields & Co's largest Q2 2026 buy was Honeywell Aerospace: 81,559 shares worth $18M.
  • Klingenstein Fields & Co added most to State Street Technology Select Sector SPDR ETF in Q2 2026, an estimated $18.2M increase.
  • Klingenstein Fields & Co's biggest Q2 2026 reduction was Honeywell, cutting an estimated $18.3M.
  • Klingenstein Fields & Co fully exited iShares TIPS Bond ETF in Q2 2026, selling an estimated $752K.
  • Klingenstein Fields & Co's ten largest holdings make up 40% of its $2.86B portfolio in Q2 2026.
  • Klingenstein Fields & Co opened 16 new positions and closed 7 in Q2 2026.
  • Klingenstein Fields & Co's portfolio value rose 13% quarter-over-quarter to $2.86B.

Based on Klingenstein Fields & Co's 13F filing for Q2 2026, filed 5 Aug 2026.